Sara Bar-Yehuda

Title: Innovator Spotlight: Sara Bar-Yehuda

Introduction: Sara Bar-Yehuda is a notable inventor based in Rishon Lezion, Israel. She holds a patent that addresses critical issues in the field of inflammation, contributing to the advancement of medical diagnostics and therapeutic strategies.

Latest Patents: Sara Bar-Yehuda's noteworthy patent involves a biological marker for inflammation, specifically the assessment of adenosine receptors (AAR) in white blood cells. This innovative assay enables the identification of an inflammatory state in a subject by measuring the level of AAR expression in circulating white blood cells. A heightened expression of AAR indicates significant inflammation, facilitating the determination of severity and the monitoring of anti-inflammatory treatments. Furthermore, this invention can aid in selecting appropriate patients for treatment involving AAR agonists.

Career Highlights: Sara is currently associated with Can-Fite Biopharma Ltd., a company dedicated to developing innovative drug therapies for inflammatory and cancer-related conditions. Her role involves applying her expertise in research and patent innovation to further the company’s mission of improving patient outcomes through groundbreaking therapies.

Collaborations: Throughout her career, Sara has worked closely with esteemed colleagues, including Pnina Fishman and Lea Madi. These collaborations reflect a synergistic approach to innovation within Can-Fite Biopharma Ltd., fostering a dynamic environment that enhances scientific research and development efforts.

Conclusion: Sara Bar-Yehuda stands out as a pioneering inventor with her patent on a biological marker for inflammation, indicating her significant contributions to the medical field. Her work at Can-Fite Biopharma Ltd. and collaborations with fellow researchers highlight her commitment to advancing healthcare through innovation and technology.